GO
Loading...

St. Jude Medical Inc

More

  • Midday Glance: Medical Devices companies Wednesday, 30 Jul 2014 | 1:22 PM ET

    Allergan rose $1.25 or. 7 percent, to $172.15. Baxter International Inc. rose$. 07 or. 1 percent, to $76.41. Boston Scientific Corp. rose$. 18 or 1.4 percent, to $13.07.

  • Early Glance: Medical Devices companies Wednesday, 30 Jul 2014 | 10:42 AM ET

    Allergan rose $1.15 or. 7 percent, to $172.05. Baxter International Inc. rose$. 54 or. 7 percent, to $76.88. Boston Scientific Corp. rose$. 02 or. 2 percent, to $12.91.

  • Final Glance: Medical Devices companies Monday, 28 Jul 2014 | 6:04 PM ET

    Allergan rose$. 09 or. 1 percent, to $170.15. Boston Scientific Corp. fell$. 14 or 1.1 percent, to $12.97. Medtronic fell$. 14 or. 2 percent, to $62.76.

  • Midday Glance: Medical Devices companies Monday, 28 Jul 2014 | 1:31 PM ET

    Allergan fell$. 02 or percent, to $170.04. Baxter International Inc. fell$. 28 or. 4 percent, to $76.38. Boston Scientific Corp. fell$. 20 or 1.5 percent, to $12.91.

  • Early Glance: Medical Devices companies Monday, 28 Jul 2014 | 10:33 AM ET

    Allergan rose$. 55 or. 3 percent, to $170.61. Baxter International Inc. fell$. 10 or. 1 percent, to $76.55. Boston Scientific Corp. fell$. 14 or 1.1 percent, to $12.97.

  • Final Glance: Medical Devices companies Thursday, 24 Jul 2014 | 6:22 PM ET

    Allergan fell $1.86 or 1.1 percent, to $170.57. Baxter International Inc. rose$. 16 or. 2 percent, to $77.00. Boston Scientific Corp. rose$. 24 or 1.8 percent, to $13.26.

  • Midday Glance: Medical Devices companies Thursday, 24 Jul 2014 | 1:23 PM ET

    Allergan fell$. 78 or. 5 percent, to $171.65. Baxter International Inc. rose$. 20 or. 3 percent, to $77.04. Boston Scientific Corp. rose$. 09 or. 7 percent, to $13.11.

  • Early Glance: Medical Devices companies Thursday, 24 Jul 2014 | 11:37 AM ET

    Allergan fell $1.51 or. 9 percent, to $170.92. Baxter International Inc. fell$. 13 or. 2 percent, to $76.71. Boston Scientific Corp. rose$. 02 or. 2 percent, to $13.04.

  • Final Glance: Medical Devices companies Tuesday, 22 Jul 2014 | 6:02 PM ET

    Allergan fell$. 71 or. 4 percent, to $170.43. Boston Scientific Corp. rose$. 30 or 2.4 percent, to $12.85. Medtronic rose$. 30 or. 5 percent, to $62.71.

  • Early Glance: Medical Devices companies Tuesday, 22 Jul 2014 | 11:16 AM ET

    Allergan rose $1.04 or. 6 percent, to $172.18. Baxter International Inc. rose$. 55 or. 7 percent, to $76.66. Boston Scientific Corp. rose$. 23 or 1.8 percent, to $12.78.

  • Midday Glance: Medical Devices companies Friday, 18 Jul 2014 | 1:19 PM ET

    Allergan rose $1.25 or. 8 percent, to $167.07. Baxter International Inc. fell$. 25 or. 3 percent, to $76.00. Boston Scientific Corp. rose$. 18 or 1.4 percent, to $12.64.

  • UPDATE 2-St. Jude not keen to join inversion deal craze Wednesday, 16 Jul 2014 | 3:39 PM ET

    In the most recent such deal in the medical device sector, Medtronic Inc last month agreed to buy Covidien for $43 billion. The move will allow Medtronic to re-domicile to Ireland to take advantage of low corporate tax rates and to access cash overseas without having to pay high repatriation costs.

  • Will earnings tell the story markets need to hear? Sunday, 13 Jul 2014 | 6:21 PM ET
    Traders work the floor of the New York Stock Exchange before the closing bell in New York.

    Quarterly earnings growth and clues from companies' commentaries will tell whether there really will be a bounce back in growth in the second half.

  • July 2- St. Jude Medical Inc said the U.S. Food and Drug Administration notified the company that issues regarding its Sylmar, California- based manufacturing plant have been resolved. The FDA last year had warned St.

  • July 2- St. Jude Medical Inc said the U.S. Food and Drug Administration notified the company that issues regarding its Sylmar, California- based manufacturing plant have been resolved. The FDA last year had warned St. Jude of serious violations at the plant where the Durata and Riata leads for implantable defibrillators are made.

  • June 16- Medtronic Inc's $43 billion deal for Dublin- based Covidien Plc should accelerate already intense efforts by medical device rivals to seek merger partners, industry analysts and bankers said on Monday.

  • Medtronic’s $43B Covidien deal: More to come? Monday, 16 Jun 2014 | 9:26 AM ET
    Medtronic Chairman and Chief Executive Omar Ishrak.

    Medtronic's $43 billion Covidien deal may signal future medical-device company mergers.

  • *Schroders urges AstraZeneca to restart talks with Pfizer. LONDON, May 20- Schroders, AstraZeneca's 12th- biggest shareholder, urged the drugmaker to restart takeover talks with Pfizer as rival Fidelity Worldwide Investment, ranking 18th, backed the British company's stance.

  • *Schroders urges AstraZeneca to restart talks with Pfizer. LONDON, May 20- Schroders, AstraZeneca's 12th- biggest shareholder, urged the drugmaker to restart takeover talks with Pfizer as rival Fidelity, ranking 18th, backed the British company's stance.

  • LONDON, May 20- AstraZeneca shareholder Schroders urged the company to restart takeover talks with Pfizer, adding its voice to criticism of the British drugmaker's rejection of the U.S. firm's 70 billion pound bid. Schroders is AstraZeneca's twelfth-largest shareholder with a 2 percent stake.